Oxacillinase-Mediated Resistance to Cefepime and Susceptibility to Ceftazidime in<i>Pseudomonas aeruginosa</i>

Daniel Aubert, Laurent Poirel, Jacqueline Chevalier, Sophie Léotard, Jean‐Marie Pagès, Patrice Nordmann

Antimicrobial Agents and Chemotherapy · 2001 · 112 citations · 32 references

DOIFull text

Open access

Concepts

Abstract

Pseudomonas aeruginosa clinical isolate SOF-1 was resistant to cefepime and susceptible to ceftazidime. This resistance phenotype was explained by the expression of OXA-31, which shared 98% amino acid identity with a class D beta-lactamase, OXA-1. The oxa-31 gene was located on a ca. 300-kb nonconjugative plasmid and on a class 1 integron. No additional efflux mechanism for cefepime was detected in P. aeruginosa SOF-1. Resistance to cefepime and susceptibility to ceftazidime in P. aeruginosa were conferred by OXA-1 as well.

References

32